Finland· FI-REL-REL51025
Lynparza
A olaparib product containing olaparib, registered in Finland by AstraZeneca AB. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Olaparib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XK01 (olaparib), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Olaparib · ATC L01XK01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of olaparib costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.27 in France to $413.52 in Switzerland — a ×1533 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Olaparib · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$413.52
- FR France$0.27
The record
At a glance
Fimea (Finland)- Active substance
- Olaparib
- Manufacturer
- AstraZeneca AB
- Country
- Finland (FI)
- ATC code
- L01XK01
- ATC class
- Olaparib
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa56722856EUR 2196.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
507 interactions on record for olaparib.
Graded by severity as the source publishes them — 104 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olaparib · interactions on record
507 records
- 104 severe
- 400 moderate
- 3 minor
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- DronedaroneC01BD07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olaparib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLYNPARZA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- SwitzerlandLynparza 100 mg, FilmtablettenAstraZeneca AG
- CzechiaLYNPARZAAstraZeneca AB, Södertälje
- United StatesLynparzaAstraZeneca Pharmaceuticals LP
- IcelandLynparzaAstraZeneca AB
- NetherlandsLynparza 100 mg filmomhulde tablettenAstraZeneca AB (Kvarnbergagatan)
- NorwayLynparzaAstraZeneca AB (2)
- PolandLynparzaAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lynparza
- Liechtenstein · Lynparza
- Norway · Lynparza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f59168d8-8fd4-4425-8eb8-b9a6b839188f GET /v1/drugs/f59168d8-8fd4-4425-8eb8-b9a6b839188f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.6",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "100 mg",
"atc_label": "olaparibi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/14/959/002-003",
"fimea_rel_id": "REL51025",
"authorised_at": "2018-05-08"
}See everything about olaparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.